PositiveID Corporation Announces First Quarter 2012 Accomplishments: Positions Itself for $3 Billion BioWatch Contract and Advances the Development of Its Diabetes Management Products
April 02, 2012 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., April 2, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes...
PositiveID Corporation to Launch Clinical Trial of Its Easy Check Non-Invasive Breath Glucose Detection Device This Month
January 05, 2012 10:23 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Jan. 5, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today it...
PositiveID Corporation Partners With Diabetes Research Institute at the University of Miami and Schneider Children's Medical Center of Israel to Support Development of PositiveID's Diabetes Management Products
January 03, 2012 08:30 ET
|
PositiveID Corporation
Diabetes Research Institute is a Recognized World Leader in Cure-Focused Diabetes Research
Schneider Children's Medical Center of Israel is the Only Highly Specialized Care Hospital of...
PositiveID Corporation Files Patent for Glucose-Sensing System to be Used in Its GlucoChip Microchip for Patients With Diabetes
August 24, 2011 16:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Aug. 24, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical...